Trials / Completed
CompletedNCT02348632
"A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA"
A Long-Term Safety and Maintenance of Efficacy Study ofJZP-110 [(R)-2-amino-3 Phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or Obstructive Sleep Apnea
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 645 (actual)
- Sponsor
- Jazz Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a Phase 3 study to assess the long-term safety and maintenance of efficacy of JZP-110 in subjects who have completed Study 14-002, 14-003, 14-004, 15-004, 15-005, ADX-N05 201, or ADX-N05 202.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | JZP-110 |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2015-01-28
- Last updated
- 2019-06-25
- Results posted
- 2019-06-25
Locations
80 sites across 6 countries: United States, Canada, Finland, France, Germany, Netherlands
Source: ClinicalTrials.gov record NCT02348632. Inclusion in this directory is not an endorsement.